Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

The role of deubiquitinases in breast cancer.

Xiao Z, Zhang P, Ma L.

Cancer Metastasis Rev. 2016 Dec;35(4):589-600. doi: 10.1007/s10555-016-9640-2.

PMID:
27844253
2.

The tumour suppressor CYLD regulates the p53 DNA damage response.

Fernández-Majada V, Welz PS, Ermolaeva MA, Schell M, Adam A, Dietlein F, Komander D, Büttner R, Thomas RK, Schumacher B, Pasparakis M.

Nat Commun. 2016 Aug 26;7:12508. doi: 10.1038/ncomms12508.

3.

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.

Kupka S, De Miguel D, Draber P, Martino L, Surinova S, Rittinger K, Walczak H.

Cell Rep. 2016 Aug 30;16(9):2271-80. doi: 10.1016/j.celrep.2016.07.086. Epub 2016 Aug 18.

4.

The exon junction complex regulates the splicing of cell polarity gene dlg1 to control Wingless signaling in development.

Liu M, Li Y, Liu A, Li R, Su Y, Du J, Li C, Zhu AJ.

Elife. 2016 Aug 18;5. pii: e17200. doi: 10.7554/eLife.17200.

5.

Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors.

Jin YJ, Wang S, Cho J, Selim MA, Wright T, Mosialos G, Zhang JY.

JCI Insight. 2016 Jul 21;1(11). pii: e86548.

6.

Chemical ubiquitination for decrypting a cellular code.

Stanley M, Virdee S.

Biochem J. 2016 May 15;473(10):1297-314. doi: 10.1042/BJ20151195. Review. Erratum in: Biochem J. 2016 Jul 15;473(14):2249.

7.

USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds.

Madan B, Walker MP, Young R, Quick L, Orgel KA, Ryan M, Gupta P, Henrich IC, Ferrer M, Marine S, Roberts BS, Arthur WT, Berndt JD, Oliveira AM, Moon RT, Virshup DM, Chou MM, Major MB.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2945-54. doi: 10.1073/pnas.1605691113. Epub 2016 May 9.

8.

Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cells.

Ni F, Gui Z, Guo Q, Hu Z, Wang X, Chen D, Wang S.

Oncol Lett. 2016 Feb;11(2):1155-1160. Epub 2015 Dec 3.

9.

Disinhibition of the HECT E3 ubiquitin ligase WWP2 by polymerized Dishevelled.

Mund T, Graeb M, Mieszczanek J, Gammons M, Pelham HR, Bienz M.

Open Biol. 2015 Dec;5(12):150185. doi: 10.1098/rsob.150185.

10.

Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN.

Elliott PR, Komander D.

FEBS J. 2016 Jan;283(1):39-53. doi: 10.1111/febs.13547. Epub 2015 Nov 2. Review.

11.

Loss-of-Function Mutations in the WNT Co-receptor LRP6 Cause Autosomal-Dominant Oligodontia.

Massink MP, Créton MA, Spanevello F, Fennis WM, Cune MS, Savelberg SM, Nijman IJ, Maurice MM, van den Boogaard MJ, van Haaften G.

Am J Hum Genet. 2015 Oct 1;97(4):621-6. doi: 10.1016/j.ajhg.2015.08.014. Epub 2015 Sep 17.

12.

Deubiquitinase USP47/UBP64E Regulates β-Catenin Ubiquitination and Degradation and Plays a Positive Role in Wnt Signaling.

Shi J, Liu Y, Xu X, Zhang W, Yu T, Jia J, Liu C.

Mol Cell Biol. 2015 Oct;35(19):3301-11. doi: 10.1128/MCB.00373-15. Epub 2015 Jul 13.

13.

Peeling away the layers of ubiquitin signaling complexities with synthetic ubiquitin-protein conjugates.

Pham GH, Strieter ER.

Curr Opin Chem Biol. 2015 Oct;28:57-65. doi: 10.1016/j.cbpa.2015.06.001. Epub 2015 Jun 18. Review.

14.

Linear ubiquitination in immunity.

Shimizu Y, Taraborrelli L, Walczak H.

Immunol Rev. 2015 Jul;266(1):190-207. doi: 10.1111/imr.12309. Review.

15.

Deubiquitinases in cancer.

Wei R, Liu X, Yu W, Yang T, Cai W, Liu J, Huang X, Xu GT, Zhao S, Yang J, Liu S.

Oncotarget. 2015 May 30;6(15):12872-89. Review.

16.

Ubiquitination of the Dishevelled DIX domain blocks its head-to-tail polymerization.

Madrzak J, Fiedler M, Johnson CM, Ewan R, Knebel A, Bienz M, Chin JW.

Nat Commun. 2015 Apr 24;6:6718. doi: 10.1038/ncomms7718.

17.

Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.

Tsukiyama T, Fukui A, Terai S, Fujioka Y, Shinada K, Takahashi H, Yamaguchi TP, Ohba Y, Hatakeyama S.

Mol Cell Biol. 2015 Jun 1;35(11):2007-23. doi: 10.1128/MCB.00159-15. Epub 2015 Mar 30.

18.

The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling.

Rajan N, Elliott RJ, Smith A, Sinclair N, Swift S, Lord CJ, Ashworth A.

Oncotarget. 2014 Dec 15;5(23):12126-40.

19.

CYLD-mediated signaling and diseases.

Mathis BJ, Lai Y, Qu C, Janicki JS, Cui T.

Curr Drug Targets. 2015;16(4):284-94. Review.

20.

Functional analysis of dishevelled-3 phosphorylation identifies distinct mechanisms driven by casein kinase 1ϵ and frizzled5.

Bernatík O, Šedová K, Schille C, Ganji RS, Červenka I, Trantírek L, Schambony A, Zdráhal Z, Bryja V.

J Biol Chem. 2014 Aug 22;289(34):23520-33. doi: 10.1074/jbc.M114.590638. Epub 2014 Jul 3.

Supplemental Content

Support Center